Coronary endothelial function testing provides superior discrimination compared to standard clinical risk scoring in prediction of cardiovascular events

摘要

BackgroundEndothelial dysfunction is regarded as the early stage of atherosclerosis and associated with cardiovascular (CV) events. This study was designed to determine whether the assessment of coronary endothelial function (CEF) is safe and can re-classify risk in patients with early coronary artery disease beyond the Framingham risk score (FRS).